252 Recruiting Trials

Clinical Trials for Alzheimer's

Alzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.

Showing 15 of 252 recruiting trials

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NA Cambridge, Massachusetts NCT05655195
Recruiting
Low-Dose Radiotherapy for Alzheimer's Disease
PHASE1 Winter Park, Florida NCT07693140
Recruiting
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
NA Tucson, Arizona +3 more NCT07207122
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3 Fullerton, California +4 more NCT06976203
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3 Chandler, Arizona +4 more NCT07011745
Recruiting
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
PHASE3 Irvine, California +4 more NCT07717411
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3 Long Beach, California +4 more NCT06976216
Recruiting
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
PHASE1 Irvine, California +4 more NCT07599670
Recruiting
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
PHASE2 The Villages, Florida NCT07688213
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
PHASE1 Phoenix, Arizona +4 more NCT05462106
Recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
PHASE2 Phoenix, Arizona +4 more NCT07094516
Recruiting
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
PHASE2 New York, New York NCT07553338
Recruiting
Open-label Extension Study in Participants With Early Alzheimer's Disease
PHASE2 Maitland, Florida +4 more NCT07105709
Recruiting
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
PHASE1 Boston, Massachusetts NCT02649985
Recruiting
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
PHASE1 Bethesda, Maryland NCT04396873
Recruiting
See all 252 results
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Alzheimer's Trials by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon